The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Mammography


Psychiatry related information on Mammography

  • Significant effects reported included reductions in cholesterol and blood pressure levels, weight, and disease symptoms and increases in the use of mammography and breast self-examination [6].
  • CONCLUSIONS: Preliminary evaluations of the CADMIUM II prototype reinforce the value of representing explicitly decision making processes in computer aided mammography and of deriving these processes from image processing measurements [7].
  • The behaviors studied were smoking cessation, quitting cocaine, weight control, high-fat diets, adolescent delinquent behaviors, safer sex, condom use, sunscreen use, radon gas exposure, exercise acquisition, mammography screening, and physicians' preventive practices with smokers [8].
  • The authors examined the impact of psychological distress and the personality construct of conscientiousness (as measured by the Neuroticism, Extraversion, and Openness-Five Factor Inventory) on mammography utilization among women who were at increased risk for breast cancer [9].
  • The first Navajo-language video to address such cultural barriers, it discusses the triad of early detection-breast self-examination, clinical examination, and mammography [10].

High impact information on Mammography


Chemical compound and disease context of Mammography


Biological context of Mammography


Anatomical context of Mammography


Associations of Mammography with chemical compounds

  • The Women's Leadership Summit on Mammography held at the U.S. Capitol [27].
  • METHODS: We obtained formalin-fixed biopsy specimens of breast tissue excised from 128 patients with breast lesions detected by mammography [28].
  • Nonetheless, in patients younger than 60 years of age, both 6 and 12 months of therapy compared favorably with other established medical interventions, such as screening mammography and cholesterol reduction programs [29].
  • SETTING: Mammography registries in California (n = 1), New Hampshire (n = 1), New Mexico (n = 1), Vermont (n = 1), Washington State n = 2), and Colorado (n = 1) [30].
  • Measured mammography spectra for a molybdenum target-molybdenum filter unit were utilized [31].

Gene context of Mammography

  • Screening with clinical breast examination and mammography showed lower sensitivity in BRCA1 or BRCA2 carriers than in the general population [32].
  • The difference between CE MRI and mammography sensitivities was particularly pronounced in BRCA1 carriers (13 cancers; 92%vs 23%, p=0.004) [33].
  • RESULTS: Mammography use between waves increased significantly (P < 0.05 after adjusting for education, income, and age) in all but one area (from 19% to 33% in wave 1 to 35% to 59% in wave 2) [34].
  • Sixty-eight BRCA-families underwent surveillance using annual mammography, transvaginal ultrasound, and estimation of CA125 [35].
  • Pilot studies of aromatase inhibitors described elsewhere in this session have begun in healthy women with dense mammography, or a high-risk genetic and/or histocytopathologic profile, to determine potential efficacy, as well as effects on end-organ function [36].

Analytical, diagnostic and therapeutic context of Mammography


  1. News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer. Schwartz, L.M., Woloshin, S. JAMA (2002) [Pubmed]
  2. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. Warner, E., Plewes, D.B., Shumak, R.S., Catzavelos, G.C., Di Prospero, L.S., Yaffe, M.J., Goel, V., Ramsay, E., Chart, P.L., Cole, D.E., Taylor, G.A., Cutrara, M., Samuels, T.H., Murphy, J.P., Murphy, J.M., Narod, S.A. J. Clin. Oncol. (2001) [Pubmed]
  3. Breast and chest wall hemorrhage after routine mammography in a patient receiving heparin. Hollenberg, G.M., Van Zandt, T.F. Radiology. (1995) [Pubmed]
  4. Prospective study of dietary acrylamide and risk of colorectal cancer among women. Mucci, L.A., Adami, H.O., Wolk, A. Int. J. Cancer (2006) [Pubmed]
  5. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine. Pediconi, F., Catalano, C., Occhiato, R., Venditti, F., Fraioli, F., Napoli, A., Kirchin, M.A., Passariello, R. Radiology. (2005) [Pubmed]
  6. Health programs in faith-based organizations: are they effective? DeHaven, M.J., Hunter, I.B., Wilder, L., Walton, J.W., Berry, J. American journal of public health. (2004) [Pubmed]
  7. Elicitation and representation of expert knowledge for computer aided diagnosis in mammography. Alberdi, E., Taylor, P., Lee, R. Methods of information in medicine. (2004) [Pubmed]
  8. Stages of change and decisional balance for 12 problem behaviors. Prochaska, J.O., Velicer, W.F., Rossi, J.S., Goldstein, M.G., Marcus, B.H., Rakowski, W., Fiore, C., Harlow, L.L., Redding, C.A., Rosenbloom, D. Health psychology : official journal of the Division of Health Psychology, American Psychological Association. (1994) [Pubmed]
  9. Distress, personality, and mammography utilization among women with a family history of breast cancer. Schwartz, M.D., Taylor, K.L., Willard, K.S., Siegel, J.E., Lamdan, R.M., Moran, K. Health psychology : official journal of the Division of Health Psychology, American Psychological Association. (1999) [Pubmed]
  10. Breast cancer education for Native American women: creating culturally relevant communications. Robinson, F., Sandoval, N., Baldwin, J., Sanderson, P.R. Clinical journal of oncology nursing. (2005) [Pubmed]
  11. Benefits and risks of screening mammography in women with BRCA1 and BRCA2 mutations. Gilson, E. JAMA (1997) [Pubmed]
  12. Benefits and risks of screening mammography in women with BRCA1 and BRCA2 mutations. Vaidya, J.S., Baum, M. JAMA (1997) [Pubmed]
  13. Estrogen and the postmenopausal breast. Mammographic considerations. Peck, D.R., Lowman, R.M. JAMA (1978) [Pubmed]
  14. Does practice make perfect when interpreting mammography? Part II. Elmore, J.G., Miglioretti, D.L., Carney, P.A. J. Natl. Cancer Inst. (2003) [Pubmed]
  15. Effect of clinical features on the association of estrogens and breast cancer. Horwitz, R.I., Stewart, K.R. Am. J. Med. (1984) [Pubmed]
  16. Milk and lactose intakes and ovarian cancer risk in the Swedish Mammography Cohort. Larsson, S.C., Bergkvist, L., Wolk, A. Am. J. Clin. Nutr. (2004) [Pubmed]
  17. The possible role of lipid peroxidation in breast cancer risk. Boyd, N.F., McGuire, V. Free Radic. Biol. Med. (1991) [Pubmed]
  18. Accuracy of technetium-99m sestamibi scintimammography and X-ray mammography in premenopausal women with suspected breast cancer. Lumachi, F., Ferretti, G., Povolato, M., Marzola, M.C., Zucchetta, P., Geatti, O., Brandes, A.A., Bui, F. European journal of nuclear medicine. (2001) [Pubmed]
  19. The use of thallium-201 in the preoperative detection of breast cancer: an adjunct to mammography and ultrasonography. Cimitan, M., Volpe, R., Candiani, E., Gusso, G., Ruffo, R., Borsatti, E., Massarut, S., Rossi, C., Morassut, S., Carbone, A. European journal of nuclear medicine. (1995) [Pubmed]
  20. Women's receptivity to testing for a genetic susceptibility to breast cancer. Chaliki, H., Loader, S., Levenkron, J.C., Logan-Young, W., Hall, W.J., Rowley, P.T. American journal of public health. (1995) [Pubmed]
  21. Equity in prevention and health care. Lorant, V., Boland, B., Humblet, P., Deliège, D. Journal of epidemiology and community health. (2002) [Pubmed]
  22. Management of women at increased risk for breast cancer: preliminary results from a new program. Chart, P.L., Franssen, E. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. (1997) [Pubmed]
  23. Cost/benefit of high technology in diagnostic radiology. Göthlin, J.H. European journal of radiology. (1987) [Pubmed]
  24. Use of preventive health behaviors by lesbian, bisexual, and heterosexual women: questionnaire survey. Koh, A.S. West. J. Med. (2000) [Pubmed]
  25. Detection of axillary lymph node metastases in breast carcinoma by technetium-99m sestamibi breast scintigraphy, ultrasound and conventional mammography. Lam, W.W., Yang, W.T., Chan, Y.L., Stewart, I.E., Metreweli, C., King, W. European journal of nuclear medicine. (1996) [Pubmed]
  26. Mutagenicity of low-filtered 30 kVp X-rays, mammography X-rays and conventional X-rays in cultured mammalian cells. Frankenberg-Schwager, M., Garg, I., Fran-Kenberg, D., Greve, B., Severin, E., Uthe, D., Göhde, W. Int. J. Radiat. Biol. (2002) [Pubmed]
  27. The Women's Leadership Summit on Mammography held at the U.S. Capitol. Wittenberg, C.K. J. Natl. Cancer Inst. (1989) [Pubmed]
  28. Nm23 protein expression in ductal in situ and invasive human breast carcinoma. Royds, J.A., Stephenson, T.J., Rees, R.C., Shorthouse, A.J., Silcocks, P.B. J. Natl. Cancer Inst. (1993) [Pubmed]
  29. Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C. Kim, W.R., Poterucha, J.J., Hermans, J.E., Therneau, T.M., Dickson, E.R., Evans, R.W., Gross, J.B. Ann. Intern. Med. (1997) [Pubmed]
  30. Performance of screening mammography among women with and without a first-degree relative with breast cancer. Kerlikowske, K., Carney, P.A., Geller, B., Mandelson, M.T., Taplin, S.H., Malvin, K., Ernster, V., Urban, N., Cutter, G., Rosenberg, R., Ballard-Barbash, R. Ann. Intern. Med. (2000) [Pubmed]
  31. Normalized average glandular dose in magnification mammography. Liu, B., Goodsitt, M., Chan, H.P. Radiology. (1995) [Pubmed]
  32. Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature. Calderon-Margalit, R., Paltiel, O. Int. J. Cancer (2004) [Pubmed]
  33. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Leach, M.O., Boggis, C.R., Dixon, A.K., Easton, D.F., Eeles, R.A., Evans, D.G., Gilbert, F.J., Griebsch, I., Hoff, R.J., Kessar, P., Lakhani, S.R., Moss, S.M., Nerurkar, A., Padhani, A.R., Pointon, L.J., Thompson, D., Warren, R.M. Lancet (2005) [Pubmed]
  34. Breast cancer screening among women from 65 to 74 years of age in 1987-88 and 1991. NCI Breast Cancer Screening Consortium. Coleman, E.A., Feuer, E.J. Ann. Intern. Med. (1992) [Pubmed]
  35. Early detection of breast and ovarian cancer in families with BRCA mutations. Vasen, H.F., Tesfay, E., Boonstra, H., Mourits, M.J., Rutgers, E., Verheyen, R., Oosterwijk, J., Beex, L. Eur. J. Cancer (2005) [Pubmed]
  36. Breast cancer prevention--clinical trials strategies involving aromatase inhibitors. Goss, P.E. J. Steroid Biochem. Mol. Biol. (2003) [Pubmed]
  37. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. Kuhl, C.K., Schrading, S., Leutner, C.C., Morakkabati-Spitz, N., Wardelmann, E., Fimmers, R., Kuhn, W., Schild, H.H. J. Clin. Oncol. (2005) [Pubmed]
  38. Magnification mammography: a low-dose technique. Arnold, B.A., Eisenberg, H., Bjarngard, B.E. Radiology. (1979) [Pubmed]
  39. MR imaging of the breast with Gd-DTPA: use and limitations. Heywang, S.H., Wolf, A., Pruss, E., Hilbertz, T., Eiermann, W., Permanetter, W. Radiology. (1989) [Pubmed]
  40. Results of preliminary clinical trials of the positron emission mammography system PEM-I: a dedicated breast imaging system producing glucose metabolic images using FDG. Murthy, K., Aznar, M., Thompson, C.J., Loutfi, A., Lisbona, R., Gagnon, J.H. J. Nucl. Med. (2000) [Pubmed]
  41. Black-white differences in cancer prevention knowledge and behavior. Jepson, C., Kessler, L.G., Portnoy, B., Gibbs, T. American journal of public health. (1991) [Pubmed]
WikiGenes - Universities